Sun Pharmaceutical Industries Ltd. closed 9.91% short of its 52-week high of 1,960.20 rupees, which the company reached on ...
Shares of Sun Pharmaceutical Industries Ltd. 524715 inched up 0.08% to 1,785.30 Indian rupees Monday, on what proved to be an ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...
On Tuesday, India’s top specialty generics company Sun Pharma announced the acquisition of the US-based Checkpoint for $355 million to enhance its oncology portfolio. Analysts view this ...
Vogue Williams has revealed she’s ‘had enough’ after a ‘tiff’ with husband Spencer Matthews, sharing their workloads at home ...
The share price of Sun Pharmaceuticals Industries (Sun Pharma) is shining bright, the top gainer in intra-day trade, up 3%. This surge in the share price came after the company announced an ...
Rigrodsky Law, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities ...
Sun Pharmaceutical Industries has agreed to acquire ... The upfront cash payment of $4.1 per share of common stock represents a premium of approximately 66 percent to Checkpoint’s closing ...
Sun Pharma shares rise over 3% with positive brokerage outlook as firm to acquire US biotech company
Sun Pharmaceutical Industries Limited shares ... it has set a target price of Rs 1,895 based on 31x FY 2027 estimated earnings per share (32x on FY 2026 estimates earnings per share earlier).
Upon completion of the transaction, Sun Pharma will acquire all outstanding shares of Checkpoint and Checkpoint stockholders will receive, for each share of common stock they hold, an upfront cash ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results